Nanodimensional Polymeric Therapeutics for Tumor Immunotherapy:
"CHEMICAL DESIGN – bioMEDICAL APPLICATIONS"
The Collaborative Research Center CRC 1066 invites you to join us at the international Symposium Nanodimensional Polymeric Therapeutics for Tumor Immunotherapy: "CHEMICAL DESIGN – bioMEDICAL APPLICATIONS" on September 15-16, 2016. More information can be found in the flyer.
The symposium's program is now available. Get an impression on the schedule and topics discussed here!
Our board of speakers' invitation:
"While vaccination against infectious diseases has revolutionized human health care in the last century, it is still difficult to transfer this strategy to the treatment of diseases originating in the body’s own tissue such as cancer. Here the immune system is usually “silenced” or tolerated to these “auto-pathogens”. One strategy to activate the immune system against cancer is the elimination of tolerance and its activation against tumor antigens. At this point, nanoparticles have a great potential: First, as carriers for activators of the immune system. Second, as nanocarriers equipped with homing-devices for targeted delivery to desired immune cell subpopulations.
These fundamental issues can only be addressed by advanced concepts of the chemical design – backed with expertise of immunologists. Our Collaborative Research Center CRC 1066 on ”Nanodimensional polymeric therapeutics for tumor immunotherapy” acts collaboratively on these scientific issues.
We happily invite you to join us at this interdisciplinary symposium which is set to discuss novel approaches and findings – fostering the communication across the disciplinary borders."
Rudolf Zentel – Katharina Landfester – Stephan Grabbe – Detlef Schuppan – Matthias Barz